T. Akahoshi et al., IN-VIVO INDUCTION OF MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Nephrology, dialysis, transplantation, 10(12), 1995, pp. 2244-2249
Background. Monocyte chemotactic and activating factor (MCAF) is a nov
el inflammatory cytokine belonging to the chemokine superfamily and st
imulates chemotaxis and activation of monocytes. Increased production
of inflammatory cytokines has been shown in patients with end-stage re
nal disease (ESRD). This study was thus conducted to determine plasma
MCAF in patients with ESRD. Methods. Plasma levels of MCAF were determ
ined by ELISA. Gene expression of MCAF in PBMC was assessed by RT-PCR
followed by southern blot hybridization. Results. Plasma MCAF in 72 pa
tients with long-term haemodialysis (HD) (162.4 +/- 58.2 pg/ml) and ei
ght uraemic patients not yet dialysed (167.6 +/- 57.7 pg/ml) was found
to exceed significantly the level in 24 normal subjects (86.0 +/- 19.
4 pg/ml). MCAF before HD session in long-term HD patients was the same
whether HD was carried out with either cellulosic (CUP) or synthetic
(PMMA) membrane dialysers. Intradialytic increase in plasma MCAF durin
g a single HD session was observed in both patient groups dialysed wit
h CUP or PMMA membranes. The results of RT-PCR analysis indicated that
haemodialysis stimulates the gene expression of MCAF in PBMC in vivo.
Conclusions. The present results indicate that increased levels of pl
asma MCAF may promote the activation of monocytes in patients with ESR
D.